Home
Browse
Search
Statistics
About
Usage
PMID: 25270578
Brewer FK, Follit CA, Vogel PD, Wise JG
In silico screening for inhibitors of p-glycoprotein that target the nucleotide binding domains.
Mol Pharmacol. 2014 Dec;86(6):716-26. doi: 10.1124/mol.114.095414. Epub 2014 Sep 30.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
289
ABCB1 p.Tyr401Leu
X
ABCB1 p.Tyr401Leu 25270578:289:414
status:
NEW
view ABCB1 p.Tyr401Leu details
ABCB1 p.Val801Ser
X
ABCB1 p.Val801Ser 25270578:289:750
status:
NEW
view ABCB1 p.Val801Ser details
ABCB1 p.Asn428Ala
X
ABCB1 p.Asn428Ala 25270578:289:510
status:
NEW
view ABCB1 p.Asn428Ala details
ABCB4 p.Pro1162Thr
X
ABCB4 p.Pro1162Thr 25270578:289:1201
status:
NEW
view ABCB4 p.Pro1162Thr details
ABCB1 p.Leu443Val
X
ABCB1 p.Leu443Val 25270578:289:798
status:
NEW
view ABCB1 p.Leu443Val details
ABCB1 p.Asp521Pro
X
ABCB1 p.Asp521Pro 25270578:289:462
status:
NEW
view ABCB1 p.Asp521Pro details
ABCB1 p.Gly430Gln
X
ABCB1 p.Gly430Gln 25270578:289:574
status:
NEW
view ABCB1 p.Gly430Gln details
ABCB1 p.Ile160Thr
X
ABCB1 p.Ile160Thr 25270578:289:286
status:
NEW
view ABCB1 p.Ile160Thr details
ABCB1 p.Gly525Ser
X
ABCB1 p.Gly525Ser 25270578:289:590
status:
NEW
view ABCB1 p.Gly525Ser details
ABCB1 p.Asn1043Glu
X
ABCB1 p.Asn1043Glu 25270578:289:942
status:
NEW
view ABCB1 p.Asn1043Glu details
ABCB1 p.Val1052Ile
X
ABCB1 p.Val1052Ile 25270578:289:1075
status:
NEW
view ABCB1 p.Val1052Ile details
ABCB1 p.Val524Asn
X
ABCB1 p.Val524Asn 25270578:289:558
status:
NEW
view ABCB1 p.Val524Asn details
ABCB1 p.His518Tyr
X
ABCB1 p.His518Tyr 25270578:289:430
status:
NEW
view ABCB1 p.His518Tyr details
ABCB1 p.Tyr1087Pro
X
ABCB1 p.Tyr1087Pro 25270578:289:1219
status:
NEW
view ABCB1 p.Tyr1087Pro details
ABCB1 p.Ser1077Phe
X
ABCB1 p.Ser1077Phe 25270578:289:1111
status:
NEW
view ABCB1 p.Ser1077Phe details
ABCB1 p.Gln530Gly
X
ABCB1 p.Gln530Gly 25270578:289:686
status:
NEW
view ABCB1 p.Gln530Gly details
ABCB1 p.Tyr444Arg
X
ABCB1 p.Tyr444Arg 25270578:289:830
status:
NEW
view ABCB1 p.Tyr444Arg details
ABCB1 p.Arg905Ala
X
ABCB1 p.Arg905Ala 25270578:289:1025
status:
NEW
view ABCB1 p.Arg905Ala details
ABCB4 p.Gln1118Asn
X
ABCB4 p.Gln1118Asn 25270578:289:1255
status:
NEW
view ABCB4 p.Gln1118Asn details
ABCB1 p.Phe399Leu
X
ABCB1 p.Phe399Leu 25270578:289:382
status:
NEW
view ABCB1 p.Phe399Leu details
ABCB1 p.Leu516Asp
X
ABCB1 p.Leu516Asp 25270578:289:366
status:
NEW
view ABCB1 p.Leu516Asp details
ABCB4 p.Gly432Leu
X
ABCB4 p.Gly432Leu 25270578:289:638
status:
NEW
view ABCB4 p.Gly432Leu details
ABCB1 p.Ser802Thr
X
ABCB1 p.Ser802Thr 25270578:289:782
status:
NEW
view ABCB1 p.Ser802Thr details
ABCB1 p.Pro1045His
X
ABCB1 p.Pro1045His 25270578:289:1008
status:
NEW
view ABCB1 p.Pro1045His details
ABCB1 p.Gln1081Leu
X
ABCB1 p.Gln1081Leu 25270578:289:1183
status:
NEW
view ABCB1 p.Gln1081Leu details
ABCB1 p.Cys431Val
X
ABCB1 p.Cys431Val 25270578:289:606
status:
NEW
view ABCB1 p.Cys431Val details
ABCB1 p.Ser429Val
X
ABCB1 p.Ser429Val 25270578:289:542
status:
NEW
view ABCB1 p.Ser429Val details
ABCB1 p.Phe804Gln
X
ABCB1 p.Phe804Gln 25270578:289:846
status:
NEW
view ABCB1 p.Phe804Gln details
ABCB1 p.Gln438Ile
X
ABCB1 p.Gln438Ile 25270578:289:766
status:
NEW
view ABCB1 p.Gln438Ile details
ABCB1 p.Leu531Lys
X
ABCB1 p.Leu531Lys 25270578:289:718
status:
NEW
view ABCB1 p.Leu531Lys details
ABCB1 p.Ile409Glu
X
ABCB1 p.Ile409Glu 25270578:289:478
status:
NEW
view ABCB1 p.Ile409Glu details
ABCB1 p.Lys1164Val
X
ABCB1 p.Lys1164Val 25270578:289:1291
status:
NEW
view ABCB1 p.Lys1164Val details
ABCB4 p.Gln1280Thr
X
ABCB4 p.Gln1280Thr 25270578:289:1309
status:
NEW
view ABCB4 p.Gln1280Thr details
ABCB4 p.Ile585Val
X
ABCB4 p.Ile585Val 25270578:289:926
status:
NEW
view ABCB4 p.Ile585Val details
ABCB1 p.Arg262Ile
X
ABCB1 p.Arg262Ile 25270578:289:302
status:
NEW
view ABCB1 p.Arg262Ile details
ABCB1 p.Asn809Gln
X
ABCB1 p.Asn809Gln 25270578:289:910
status:
NEW
view ABCB1 p.Asn809Gln details
ABCB1 p.Thr522Ile
X
ABCB1 p.Thr522Ile 25270578:289:494
status:
NEW
view ABCB1 p.Thr522Ile details
ABCB1 p.Phe601Asn
X
ABCB1 p.Phe601Asn 25270578:289:992
status:
NEW
view ABCB1 p.Phe601Asn details
ABCB1 p.Tyr1044Ile
X
ABCB1 p.Tyr1044Ile 25270578:289:975
status:
NEW
view ABCB1 p.Tyr1044Ile details
ABCB1 p.Glu556Thr
X
ABCB1 p.Glu556Thr 25270578:289:894
status:
NEW
view ABCB1 p.Glu556Thr details
ABCB1 p.Ile1158Gln
X
ABCB1 p.Ile1158Gln 25270578:289:1129
status:
NEW
view ABCB1 p.Ile1158Gln details
ABCB1 p.Pro517Phe
X
ABCB1 p.Pro517Phe 25270578:289:398
status:
NEW
view ABCB1 p.Pro517Phe details
ABCB1 p.Thr1078Ile
X
ABCB1 p.Thr1078Ile 25270578:289:1147
status:
NEW
view ABCB1 p.Thr1078Ile details
ABCB1 p.Leu1161Gly
X
ABCB1 p.Leu1161Gly 25270578:289:1165
status:
NEW
view ABCB1 p.Leu1161Gly details
ABCB1 p.Trp803Thr
X
ABCB1 p.Trp803Thr 25270578:289:814
status:
NEW
view ABCB1 p.Trp803Thr details
ABCB1 p.Lys433Asp
X
ABCB1 p.Lys433Asp 25270578:289:670
status:
NEW
view ABCB1 p.Lys433Asp details
ABCB1 p.Gln475Ser
X
ABCB1 p.Gln475Ser 25270578:289:862
status:
NEW
view ABCB1 p.Gln475Ser details
ABCB1 p.Phe1157Val
X
ABCB1 p.Phe1157Val 25270578:289:1093
status:
NEW
view ABCB1 p.Phe1157Val details
ABCB1 p.Thr1167Arg
X
ABCB1 p.Thr1167Arg 25270578:289:1273
status:
NEW
view ABCB1 p.Thr1167Arg details
ABCB1 p.Ser434Arg
X
ABCB1 p.Ser434Arg 25270578:289:702
status:
NEW
view ABCB1 p.Ser434Arg details
ABCB4 p.Asp805Tyr
X
ABCB4 p.Asp805Tyr 25270578:289:878
status:
NEW
view ABCB4 p.Asp805Tyr details
TABLE 2 Identification of protein residues in P-gp that were within 5.0 &#c5; of docked inhibitors Compound Compound 19 (ATP-binding site) Compound 29 (Allosteric binding site) Compound 34 (ADP-binding site) Compound 45 (ATP-binding site) Residues within 5.0 &#c5; of docked inhibitors
ILE 160 THR
422
ARG 262 ILE
160 GLY 161 VAL 423 THR 483 GLY 161 ASP 164 ALA 424
LEU 516 ASP
164
PHE 399 LEU
552
PRO 517 PHE
399
TYR 401 LEU
554
HIS 518 TYR
401 PRO 402 THR 563
ASP 521 PRO
402
ILE 409 GLU
566
THR 522 ILE
409
ASN 428 ALA
567 LEU 523 LEU 410
SER 429 VAL
569
VAL 524 ASN
428
GLY 430 GLN
570
GLY 525 SER
429
CYS 431 VAL
571 GLU 526 GLY 430
GLY 432 LEU
573 ALA 529 CYS 431
LYS 433 ASP
574
GLN 530 GLY
432
SER 434 ARG
577
LEU 531 LYS
433 THR 435 THR 582
VAL 801 SER
434
GLN 438 ILE
583
SER 802 THR
435
LEU 443 VAL
584
TRP 803 THR
436
TYR 444 ARG
588
PHE 804 GLN
438
GLN 475 SER
590
ASP 805 TYR
444
GLU 556 THR
591
ASN 809 GLN
475
ILE 585 VAL
592
ASN 1043 GLU
556 HIS 587 ARG 593
TYR 1044 ILE
585
PHE 601 ASN
594
PRO 1045 HIS
587
ARG 905 ALA
595 ARG 1047 ARG 905 ILE 1127 ASP 596
VAL 1052 ILE
1127
PHE 1157 VAL
1273
SER 1077 PHE
1157
ILE 1158 GLN
1274
THR 1078 ILE
1158
LEU 1161 GLY
1276
GLN 1081 LEU
1161
PRO 1162 THR
1277
TYR 1087 PRO
1162 ASN 1163 LYS 1278
GLN 1118 ASN
1163
THR 1167 ARG
1279
LYS 1164 VAL
1169
GLN 1280 THR
1167 THR 1174 THR 1174 GLN 1175 GLN 1175 LEU 1176 LEU 1176 SER 1177 SER 1177 GLY 1178 GLY 1178 GLY 1179 GLY 1179 GLN 1180 GLN 1180 Other groups have shown that flavonoids are strong modulators of P-gp activity and that they interact with the NBDs of the enzyme (Di Pietro et al., 2002).
Login to comment